haylaavo

OMKARCHEM

OMKARCHEM · NSE · inactive
3.41
-0.17 (-4.75%)
as of 28 Apr 2026 close
Open
3.41
High
3.41
Low
3.41
Prev close
3.58
52w high
7.91
05 Jun 2025
52w low
3.35
30 Mar 2026
VWAP
3.41
Delivery %
—
n/a
Volume 23,987 · turnover ₹82,000 · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 10 Feb 2011
Market cap
₹7 cr
Series
BZ
F&O
No
Status
Inactive since 29 Apr 2026

Source: NSE equity master · as of 28 Apr 2026 · market cap = shares (30 Sept 2026 filing) × close

Market cap
₹7 cr
P/B
0.37
BV ₹9
ROE (TTM)
-8.2%
ROCE -7.0%
Debt / equity
0.17
P/E (TTM)
—
loss-making
P/S (TTM)
855.74
Revenue TTM
₹0 cr
Net profit TTM
₹-2 cr
Net margin TTM
-18775.6%
OPM -9790.2%
EV / EBITDA
—
Interest cover
—
Revenue growth
—
latest quarter YoY
Profit growth
—
latest quarter YoY
Dividend yield
—
last 12 months

Standalone · last four quarters to 2026-06-30 · balance sheet 2026-03-31 · tap a tile for the formula

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 11:13 IST
  • 16 Aug 2011 11:23
    General update

    Omkar Speciality Chemicals Limited has informed the Exchange that the Company have recently set up a research center at Company's Unit No. IV (F-10/1, MIDC, Badlapur, Dist.: Thane - 421503, State: Maharashtra for carrying out innovative research in the field of development of Chemical Processes and Technologies for manufacture of new molecules. As announced, vide letter dated February 21, 2011, the Company have already undertaken research work for manufacture of Anti HIV Drugs by innovative routes of synthesis. The Company's efforts in this direction have been recognized by Harvard University

  • 23 Jun 2011 11:19
    General update

    Omkar Speciality Chemicals Limited has submitted to the Exchange Vide its letter dated June 23, 2011 a copy of the updates with respect to recent developments of the Company.

    PDF · -
  • 21 Feb 2011 16:53
    General update

    Omkar Speciality Chemicals Limited has submitted to the Exchange a copy of Business Update dated February 21, 2011.

    PDF · -
Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries